← Back to Screener
Fractyl Health, Inc. Common Stock (GUTS)
Price$0.68
Value ScoreF
Growth ScoreF
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-64.70%
Price vs S&P 500 (4W)-10.07%
VGM Score15.82
Market Capitalization$107.66M
All Metrics
Book Value / Share (Quarterly)$0.06
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.59
Price vs S&P 500 (YTD)-77.31%
Gross Margin (TTM)46.24%
Net Profit Margin (TTM)-73864.52%
EPS (TTM)$-2.07
10-Day Avg Trading Volume1.70M
EPS Excl Extra (TTM)$-2.07
EPS (Annual)$-1.86
ROI (Annual)-352.00%
Gross Margin (Annual)46.24%
Cash / Share (Quarterly)$0.53
ROA (Last FY)-116.11%
Revenue Growth TTM (YoY)-96.91%
EBITD / Share (TTM)$-1.26
ROE (5Y Avg)-424.16%
Operating Margin (TTM)-100570.97%
Cash Flow / Share (Annual)$-0.59
P/B Ratio11.38x
P/B Ratio (Quarterly)31.88x
Net Income / Employee (Annual)$-1,409,500
EV / Revenue (TTM)609.73x
Net Interest Coverage (TTM)-43.27x
ROA (TTM)-148.09%
EPS Incl Extra (Annual)$-1.86
Current Ratio (Annual)4.78x
Quick Ratio (Quarterly)4.45x
3-Month Avg Trading Volume4.14M
52-Week Price Return-65.02%
Revenue / Employee (TTM)$0
P/S Ratio (Annual)1157.63x
Asset Turnover (Annual)0.00x
52-Week High$3.03
EPS Excl Extra (Annual)$-1.86
CapEx CAGR (5Y)208.29%
26-Week Price Return-56.78%
Quick Ratio (Annual)4.45x
13-Week Price Return35.99%
Total Debt / Equity (Annual)3.23x
Current Ratio (Quarterly)4.78x
Enterprise Value$56.71M
Asset Turnover (TTM)0.00x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-73864.52%
Cash / Share (Annual)$0.53
3-Month Return Std Dev99.27%
Net Income / Employee (TTM)$-1,409,500
ROE (Last FY)-1490.32%
Net Interest Coverage (Annual)-33.44x
EPS Basic Excl Extra (Annual)$-1.86
Receivables Turnover (TTM)8.45x
Total Debt / Equity (Quarterly)3.23x
EPS Incl Extra (TTM)$-2.07
ROI (TTM)-177.99%
P/S Ratio (TTM)1157.63x
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)-89.39%
Year-to-Date Return-69.15%
5-Day Price Return-21.75%
EPS Normalized (Annual)$-1.86
ROA (5Y Avg)-78.96%
Net Profit Margin (Annual)-73864.52%
Month-to-Date Return-15.83%
EBITD / Share (Annual)$-1.26
Operating Margin (Annual)-100570.97%
LT Debt / Equity (Annual)3.23x
ROI (5Y Avg)-140.00%
LT Debt / Equity (Quarterly)3.23x
EPS Basic Excl Extra (TTM)$-2.07
P/B Ratio (Annual)31.88x
Inventory Turnover (TTM)0.00x
Pretax Margin (TTM)-73864.52%
Book Value / Share (Annual)$0.06
Price vs S&P 500 (13W)27.74%
Beta0.40x
Revenue / Share (TTM)$0.00
ROE (TTM)-852.14%
52-Week Low$0.38
vGradeF
gGradeF
mGradeC
vgmGradeF
Show chart for
Earnings Surprise History
Q1 26-0.13est. -0.16
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.18
4.18
4.18
4.18
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
GUTSFractyl Health, Inc. Common Stock | F | F | C | $0.68 |
| SYKStryker Corporation | C | C | C | $305.66 |
| MMM3M Company | C | F | C | $153.76 |
| BSXBoston Scientific Corp. | C | B | D | $48.55 |
| MDLNMedline Inc. Class A common stock | C | D | D | $33.61 |
| BDXBecton, Dickinson and Co. | B | C | C | $151.16 |
| RMDResMed Inc. | C | B | C | $196.04 |
| DXCMDexCom, Inc. | C | B | C | $72.86 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $314.50 |
| SOLVSolventum Corporation | C | D | B | $81.01 |
| PENPenumbra, Inc. | F | C | B | $320.53 |
About
Fractyl Health is a metabolic therapeutics company developing treatments for type 2 diabetes and obesity. The company targets organ-level root causes to deliver durable, disease-modifying therapies rather than chronic symptom management.